Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
BiotaX has developed deep explainable AI models based on system biology that can collect, analyze, and predict multiple disease states and calculate optimal interventions supported by meta-genomic AI analysis.
CustomBiome's live biotherapeutic production technology is able to isolate targeted live microbes on the strain level (TaxonAI Output) based either on their taxonomy or gene functionality. BiotaX can package these microbes as customized live biotherapeutic products to fight dysbiosis in a personalized and disease-specific way.